The Technical AnalystExchange: NYSE Sector: Healthcare Industry: Medical Care Facilities
DaVita Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
-1.34% $135.85
America/New_York / 8 mai 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 11 914 mill |
| EPS: | 8.83 |
| P/E: | 15.39 |
| Earnings Date: | Aug 01, 2024 |
| SharesOutstanding: | 87.70 mill |
| Avg Daily Volume: | 0.888 mill |
| RATING 2024-05-08 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Buy | |
| DE: | Strong Buy | |
| P/E: | Neutral | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.00x |
| Company: PE 15.39 | sector: PE 15.43 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 1.24x |
| Company: PE 15.39 | industry: PE 12.41 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$209.01 (53.85%) $73.16 |
| Date: 2024-05-08 |
| Expected Trading Range (DAY) |
|---|
|
$ 133.00 - 138.70 ( +/- 2.10%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-04-10 | Pullin Dennis W | Sell | 0 | No securities are beneficially owned |
| 2024-03-15 | Nehra John M | Buy | 366 | Common Stock |
| 2024-03-15 | Schoppert Wendy Lee | Buy | 366 | Common Stock |
| 2024-03-15 | Berg Charles | Buy | 366 | Common Stock |
| 2024-03-15 | Schechter Adam H | Buy | 366 | Common Stock |
| INSIDER POWER |
|---|
| -26.45 |
| Last 99 transactions |
| Buy: 2 302 220 | Sell: 3 954 783 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $135.85 (-1.34% ) |
| Volume | 0.697 mill |
| Avg. Vol. | 0.888 mill |
| % of Avg. Vol | 78.50 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For DVA
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Latest Press Releases
Latest News
